Eli N. Glezer - 04 Mar 2022 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role
Chief Scientific Officer
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 Mar 2022
Net transactions value
$0
Form type
4
Filing time
08 Mar 2022, 18:04:43 UTC
Previous filing
26 May 2021
Next filing
13 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Employee Stock Option (right to buy) Award $0 +500,000 $0.000000 500,000 04 Mar 2022 Common Stock 500,000 $7.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares vest and become exercisable in 48 equal monthly installments measured from March 4, 2022.